These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4128727)

  • 1. A new vasopressin analogue and fibrinolysis.
    Gader AM; da Costa J; Cash JD
    Lancet; 1973 Dec; 2(7843):1417-8. PubMed ID: 4128727
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of cholinergic receptors in the reactions of the hemostasis system to vasopressin].
    Kalishevskaia TM; Golubeva MG; Solo'veva ME
    Fiziol Zh (1978); 1989; 35(5):9-14. PubMed ID: 2591588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: 1-Desamino-8-D-arginine vasopressin and fibrinolysis in man.
    Gader AM; Da Costa J; Cash JD
    Scott Med J; 1974 Jan; 19(1):56-7. PubMed ID: 4820014
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intravenous administration of synthetic lysine-8-vasopressin and oxytocin. Effects on blood levels of growth hormone, follicle-stimulating hormone and insulin].
    Kleinknecht D; Rosselin G; Tchobroutsky G; Dolais J
    Presse Med (1893); 1969 May; 77(23):856-8. PubMed ID: 5806688
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of inhibition of canine gastric secretion by vasopressin.
    Blum AL
    Gastroenterology; 1971 Oct; 61(4):461-9. PubMed ID: 5114637
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of lysine-8-vasopressin, oxytocin, and adrenaline on vascular smooth muscle in the human finger.
    Gaskell P
    Can J Physiol Pharmacol; 1973 Apr; 51(4):284-90. PubMed ID: 4701719
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of 8-lysine-vasopressin and synthetic analogues of release of ACTH.
    Andersson KE; Arner B; Hedner P; Mulder JL
    Acta Endocrinol (Copenh); 1972 Apr; 69(4):640-8. PubMed ID: 4335823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of lysine 8 -vasopressin on callus formation. I. Morphobiochemical study].
    Conti G; Cappelli-Gotzos B; Spreca A; Musy JP; Gotzos V; Modis L
    Acta Anat (Basel); 1971; 79(2):204-16. PubMed ID: 4107117
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the neuro-adrenocortical responses to intravenous and subcutaneous administration of lysine-8-vasopressin].
    Hoffman C; Argüelles AE; Poggi UL
    Rev Argent Endocrinol Metab; 1970 Mar; 16(1):1-6. PubMed ID: 5522629
    [No Abstract]   [Full Text] [Related]  

  • 11. (1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V
    J Med Chem; 1974 Feb; 17(2):250-2. PubMed ID: 4809260
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of mice to (8-arginine)- and (8-lysine)-vasopressins as antidiuretic hormones.
    Stewart AD
    J Endocrinol; 1973 Oct; 59(1):195-6. PubMed ID: 4748523
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of desglycinamide lysine vasopressin and its behavioral activity in rats.
    Wang SS
    Biochem Biophys Res Commun; 1972 Sep; 48(6):1511-5. PubMed ID: 5077834
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and properties of 1-deamino-8-L-homolysine-vasopressin.
    Lindeberg G; Kyncl J; Dreyfuss P; Bodanszky M
    J Med Chem; 1972 Jun; 15(6):629-31. PubMed ID: 5030930
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
    Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.
    Cash JD; Gader AM; da Costa J
    Br J Haematol; 1974 Jun; 27(2):363-4. PubMed ID: 4367720
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of venous thromboembolic disease.
    Gallus AS; Hirsh J
    Semin Thromb Hemost; 1976 Apr; 2(4):291-331. PubMed ID: 798277
    [No Abstract]   [Full Text] [Related]  

  • 19. Primate mesenteric blood flow. Effects of vasopressin and its route of delivery.
    Freedman AR; Kerr JC; Swan KG; Hobson RW
    Gastroenterology; 1978 May; 74(5 Pt 1):875-8. PubMed ID: 416990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.